Qube Research & Technologies (QRT)
ACIU icon

Qube Research & Technologies (QRT)’s AC Immune ACIU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+92,351
New +$254K ﹤0.01% 2870
2024
Q3 		– Sell
-48
Closed -$192 – 3221
2024
Q2 		$192 Hold
48
– – ﹤0.01% 3396
2024
Q1 		$142 Buy
+48
New +$172 ﹤0.01% 4161
2023
Q4 		– Sell
-186
Closed -$530 – 4299
2023
Q3 		$530 Buy
+186
New +$566 ﹤0.01% 3675
2020
Q4 		– Sell
-26,828
Closed -$131K – 1758
2020
Q3 		$131K Buy
+26,828
New +$193K ﹤0.01% 1464

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACIU Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in AC Immune (ACIU) in Q2 2026: 92,351 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #2870 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ACIU as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in ACIU in Q3 2020 and has held it in 5 quarters since. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Qube Research & Technologies (QRT) held 92,351 shares of AC Immune worth $220K as of Q2 2026.
  • AC Immune was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • AC Immune made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2870 holding.
  • Qube Research & Technologies (QRT) first reported a position in AC Immune in Q3 2020 and has held it in 5 quarters since.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.